CID 121280087

Almonertinib

Structural Information

Molecular Formula
C30H35N7O2
SMILES
CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC
InChI
InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)
InChIKey
DOEOECWDNSEFDN-UHFFFAOYSA-N
Compound name
N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

43
References

515
Patents

525.2852 Da
Monoisotopic Mass

4.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 526.29248 227.1
[M+Na]+ 548.27442 240.8
[M+NH4]+ 543.31902 232.6
[M+K]+ 564.24836 236.3
[M-H]- 524.27792 241.7
[M+Na-2H]- 546.25987 237.6
[M]+ 525.28465 234.1
[M]- 525.28575 234.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe